These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18581392)

  • 1. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
    Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
    J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
    Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
    Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
    J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multi-echo and single-echo gradient-recalled echo sequences for SPIO-enhanced liver MRI at 3 T.
    Choi JS; Kim MJ; Kim JH; Choi JY; Chung YE; Park MS; Kim KW
    Clin Radiol; 2010 Nov; 65(11):916-23. PubMed ID: 20933647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.